drug · antibody drug conjugate
patient view →izalontamab brengitecan
Phase 3updated 2mo agoby Bristol-Myers Squibb Co🔗 ChEMBL
Phase 3community read0 votes
Antibody drug conjugate drug with a maximum clinical stage of Unknown, with 1 investigational indication.
indications
indications
NSCLC
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that